Northwestern Mutual Wealth Management’s Actuate Therapeutics ACTU Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio ACTU Stock Details ACTU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$28.3K	Sell	18,518 -12,878	-41%	-$29.8K	﹤0.01%	2736
2026 Q1	$86K	Buy	31,396 +12,878	+70%	+$53.4K	﹤0.01%	2230
2025 Q4	$113K	Sell	18,518 -783	-4%	-$5.38K	﹤0.01%	2086
2025 Q3	$129K	Buy	19,301 +783	+4%	+$5.68K	﹤0.01%	1959
2025 Q2	$113K	Buy	18,518 +15,393	+493%	+$134K	﹤0.01%	1962
2025 Q1	$21.2K	Buy	+3,125	New	+$25.1K	﹤0.01%	2489

Other funds holding ACTU

BCM

BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return

Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

TCBWMS

Texas Capital Bank Wealth Management Services Dallas, Texas $1.87B AUM 24.49% 1-Year Est. Return

PVM

Palogic Value Management Dallas, Texas $306M AUM 15.41% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ADEF

ABS Direct Equity Fund Stamford, Connecticut $159M AUM 34.17% 1-Year Est. Return

Northwestern Mutual Wealth Management's ACTU Position: Q2 2026 in Review

Northwestern Mutual Wealth Management reduced its Actuate Therapeutics (ACTU) stake by 41% in Q2 2026, selling an estimated $29.8K and leaving 18,518 shares worth $28.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2736.

Northwestern Mutual Wealth Management first reported a position in ACTU in Q1 2025 and has held it in 6 quarters since. The position peaked at $129K in Q3 2025. 63 funds tracked by Wall St. Rank hold ACTU as of Q2 2026.

Northwestern Mutual Wealth Management held 18,518 shares of Actuate Therapeutics worth $28.3K as of Q2 2026.
Northwestern Mutual Wealth Management sold 12,878 Actuate Therapeutics shares in Q2 2026, an estimated $29.8K.
Actuate Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #2736 holding.
Northwestern Mutual Wealth Management first reported a position in Actuate Therapeutics in Q1 2025 and has held it in 6 quarters since.
Northwestern Mutual Wealth Management's Actuate Therapeutics position peaked at $129K in Q3 2025.
63 funds tracked by Wall St. Rank held Actuate Therapeutics as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.